Science & Transparency
The FCI is a measurement instrument in development. This page describes what it builds on — and, just as clearly, what has not yet been demonstrated.
What the FCI builds on
Where we stand — declared openly
Dynergia is in its feasibility phase (Phase 0). Concretely:
- No completed clinical validation studies of the FCI exist.
- No patient data is currently being collected.
- Any study involving patients will take place only after approval by the competent cantonal ethics committee (BASEC).
- We make no efficacy claims before evidence exists — including in sales material.
The validation programme is designed and staged: methodological review, a field study under ethics approval, publication of the results — whatever they show.
How we audit ourselves
Our audit machinery runs before the study begins. The pilot's measure of success is defined in advance — not interpreted after the fact. The measurement's error margins are quantified and re-computed by hand by two independent parties. Whether an individual metric enters the score is decided by a rule signed before the data exists. Dropouts and interruptions are analysed according to a fixed plan — not however it suits afterwards. And where the data is insufficient, the system marks the week as not scorable instead of inventing a number.
To test whether the FCI measures more than established symptom questionnaires, the pilot study collects the PHQ-8 monthly — deliberately without the suicidality item, because an unmonitored digital channel cannot responsibly carry it, and strictly separated from the product: it appears in no report.
Our commitment
Limitations are documented, not airbrushed. Where the data does not support a statement, the report says so — in those words. A measurement instrument that knows its limits is worth more than one that admits none.
Scientific enquiries (methodology, research partnerships): info@dynergia.ch